Arden Biotechnology

About Arden BioTech

Arden Biotechnology is a Lincolnshire-based start-up specialising in developing natural, cutting-edge ways to remove antimicrobials from meat production.

Run by Managing Director Chris Stanford, Arden Biotech has a reputation within the agricultural industry for its ground-breaking work in developing technology-based solutions to control pathogens that affect livestock in animal husbandry situations.

The biggest problem that Arden Biotech faces is the excruciatingly high costs that come with the type of research, development, and regulatory approval it needs to launch its pioneering products into the marketplace.

The opportunity

Arden Biotech has worked with the Myriad grant team, led by Marc Greatrex and Dr Rehman Rafiq, four times and has successfully secured Innovate UK funding for three large-scale projects.

The most recent win will fund the development of a high-tech solution that farmers can use to increase the sustainability and efficiency of their farming and livestock processes.

With another grant application currently in progress, Arden Biotech is confident it will secure the funding to transfer the technology it's developed for animals into the human biology sector.

"As a result of working with Myriad, we have secured grant funding on three separate occasions, and we're currently waiting for the results of another grant application we've made. We certainly think that with Myriad's help, we've been able to produce a powerful application."

How we helped

Before working with Myriad, Chris and his team had written and submitted an unsuccessful grant application. Although their application scored highly, it wasn't enough to win the funding they needed.

This prompted them to hire Myriad, our grant writing team, with a reputation for a diligent approach and the specialist knowledge needed to write and submit successful Innovate UK grant applications.

Thanks to our vast experience in the grant funding industry, Dr Rehman Rafiq and his team could interpret the questions being asked in the application and work with Arden Biotech to provide the answers that the grant funding examiners were looking for.

Myriad gave Arden Biotech the specialist support, attention to detail and intelligent input needed to secure funding for their crucial project at an affordable rate.

"I knew I was getting the specialist support I needed at a cost we could afford. There are fees, but in my view, they're very reasonable for the level of specialist support we get."

The reward

The Myriad grant writing team have a 75%-win rate with Arden Biotech. They've won three out of four grant applications, which is remarkable when considering how competitive the grant funding landscape is. The fourth application missed out by a whisker, but Myriad is resubmitting it and we're confident that it will win the second time around.

Aside from writing and submitting three out of four successful grant applications, the team have helped Arden Biotech reassess and validate its business strategy. The Grant team's approaches when writing the applications encourage thought, questions and assessment, which helps shape and inform future strategy.